laboratories: search

05/30/08 - Manhattan Physicians Laboratory Buys Genatom Biomedical Laboratories

Manhattan Physicians Laboratories, a newly formed independent clinical laboratory led by former Quest Diagnostics executives, has completed the acquisition of Genatom Biomedical Laboratories (Roseland, N.J.). Financial terms of the deal were not disclosed.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

MO BIO Laboratories Provides DNA Purification with Patent-Pending Inhibitor Removal Technology

MO BIO Laboratories provides a high powered line of nucleic acid isolation products specifically optimized for troublesome samples.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

Health & Fitness : Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

Nordic Naturals, Carlson Laboratories and Metagenics Announce Dismissal of Patent Infringement and Unfair Competition Suit

Nordic Naturals, Carlson Laboratories and Metagenics Announce Dismissal of Patent Infringement and Unfair Competition Suit

Nordic Naturals, Carlson Laboratories and Metagenics Announce Dismissal of Patent Infringement and Unfair Competition Suit

Nordic Naturals, Carlson Laboratories and Metagenics Announce Dismissal of Patent Infringement and Unfair Competition Suit

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich. - ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, roya

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich.--(BUSINESS WIRE)--Jul 4, 2008 - ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich.--(BUSINESS WIRE)--July 4, 2008--ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Salix Commences Patent Infringement Litigation Against Novel Laboratories

2008 JUN 8 - (NewsRx.com) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that Salix Pharmaceuticals, Inc.; Norgine, B.V. and Norgine Europe, B. V. have filed a lawsuit in the United States District Court for the District of New Jersey against Novel Laboratories, Inc. for infringement of Norgine's patent protecting MOVIPREP(R) (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution). Norgine licensed MOVIPREP to Salix for commercialization in the United States (see also Salix Pharmaceuticals, Ltd.).

U.S. FEDERAL CIRCUIT COURT OF APPEALS FULLY UPHOLDS EISAI'S FAVORABLE RULING IN ACIPHEX PATENT INFRINGEMENT LAWSUIT AGAINST TEVA PHARMACEUTICALS AND DR. REDDY'S LABORATORIES

EISAI'S FAVORABLE RULING IN ACIPHEX® PATENT INFRINGEMENT LAWSUIT AGAINST TEVA PHARMACEUTICALS AND DR. REDDY'S LABORATORIES

U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in Aciphex Patent Infringement Lawsuit Against Teva Pharmaceuticals and Dr. Reddy's Laboratories

TOKYO and WOODCLIFF LAKE, N.J., July 21, 2008 /PRNewswire/ -- With respect to Eisai's patent infringement lawsuit against Teva Pharmaceuticals and Dr. Reddy's Laboratories concerning Aciphex(R) (generic name: rabeprazole sodium tablets, Product Name in Japan: Pariet(R)), Eisai Co., Ltd. and its U.S. subsidiary Eisai Inc. (collectively "Eisai") today announce that the United States Court of Appeals for the Federal Circuit has affirmed both the United States District Court for the Southern District of New York's summary judgment ruling on the validity of Eisai's composition of matter patent and its ruling on the enforceability of the composition of matter patent.

Nordic, Carlson and Metagenics Announce Dismissal of Patent Infringement Suit

WATSONVILLE, CA - Nordic Naturals Inc., J.R. Carlson Laboratories, and Metagenics Inc. announced that they have agreed to dismiss the patent infringement suit entitled Nordic Naturals Inc. v. J.R. Carlson Laboratories Inc., and Metagenics Inc., filed by Nordic Naturals on May 2, 2007 in the US District Court for the Northern District of California.

Form 4 BIO RAD LABORATORIES For: Jun 11 Filed by: HUTTON RONALD W

Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

IMPAX ANNOUNCES FINAL SETTLEMENT OF GENERIC EFFEXOR XR PATENT SUIT

IMPAX Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to IMPAX

First European Privacy Seal Awarded to Search Engine Ixquick

Underwriters Laboratories Opens Largest Commercial North American Photovoltaic Testing and Certification Facility in Silicon Valley

Search took 0.03 seconds.